Not intended for US, Canadian and UK-based media First approved immunotherapy for rare and aggressive skin cancer in the European Union, with initial launches planned in Germany and the UK Builds on Bavencio's previous accelerated approvals in the US and recent approval in Switzerland Approval is based on data from the Javelin Merkel 200 study including durable tumor response rate and duration of response Merck and Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has
LIV-24 applies ESG Tech AI technology, revolutionising industrial sector Cuts costs, increases productivity, facilitates sustainable business
—
At present,...
TAT and International Partners Urge Thai Businesses to Prepare for Imminent EU Regulations on Sustainable Tourism
—
On September 26, at the Avani+ Riversi...
International efforts to protect and empower ASEAN's women migrant workers
—
International organisations under the United Nations (UN) and the European Un...
EXPORT PROMOTION SEMINAR TO HIGHLIGHT EXCELLENCE OF EUROPEAN FOOD
—
H.E. Mr. David Daly, Ambassador of the European Union to Thai (EU) is set to host a tw...
Vaxzevria approved in the EU as third dose booster against COVID-19
—
Approval follows CHMP recommendation for use in patients previously vaccinated with ...
'EU Sustainable Food & Craft Market' champions sustainable SMEs to mark Europe Day
—
To celebrate Europe Day 2022, the Delegation of the European Unio...
TH-EU: The Phuket Youth's Awareness Raising for Separate Collection
—
Today, the Prince of Songkhla University, Phuket Campus was the hub to learn and exc...
BLUE ELEPHANT GROUP'S STEPPE FAMILY MEETS AMBASSADOR OF THAILAND TO BELGIUM
—
H.E. Mr. Sek Wannamethee (2nd from left), Head of the Thai delegation to the...